T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Adient
ADNT
$1.54B
| $607M | 0.12% |
+10,357,941
| New | +$547M |
|
202
CarMax
KMX
$8.52B
| $598M | 0.12% |
9,291,890
-1,013,401
| -10% | -$56.9M |
|
203
Franco-Nevada
FNV
$44.7B
| $598M | 0.12% |
9,991,362
-264,052
| -3% | -$16.1M |
|
204
CVS Health
CVS
$121B
| $595M | 0.12% |
7,544,204
-6,855,888
| -48% | -$555M |
|
205
Analog Devices
ADI
$186B
| $586M | 0.12% |
8,068,521
-2,054,300
| -20% | -$140M |
|
206
Royal Caribbean
RCL
$82.9B
| $579M | 0.11% |
7,054,341
+77,587
| +1% | +$6.11M |
|
207
CME Group
CME
$96.1B
| $575M | 0.11% |
4,987,475
+58,816
| +1% | +$6.55M |
|
208
Bath & Body Works
BBWI
$3.76B
| $571M | 0.11% |
10,723,771
+2,619,424
| +32% | +$149M |
|
209
Aramark
ARMK
$16.1B
| $559M | 0.11% |
21,691,694
+3,288,259
| +18% | +$85.9M |
|
|
MSCC
210
DELISTED
Microsemi Corp
MSCC
| $554M | 0.11% |
10,256,205
+496,320
| +5% | +$24.2M |
|
211
Global Payments
GPN
$25.1B
| $553M | 0.11% |
7,969,161
+340,747
| +4% | +$24.5M |
|
212
Canadian Pacific Kansas City
CP
$82.6B
| $553M | 0.11% |
19,354,300
-8,617,615
| -31% | -$255M |
|
213
Cummins
CMI
$87B
| $552M | 0.11% |
4,041,481
-14,423
| -0.4% | -$1.93M |
|
214
United Parcel Service
UPS
$89.8B
| $550M | 0.11% |
4,799,668
+15,488
| +0.3% | +$1.75M |
|
215
Marathon Petroleum
MPC
$100B
| $549M | 0.11% |
10,908,308
+4,597,040
| +73% | +$209M |
|
216
EOG Resources
EOG
$74.2B
| $549M | 0.11% |
5,431,788
+2,679,695
| +97% | +$261M |
|
217
Revvity
RVTY
$13.1B
| $535M | 0.11% |
10,255,317
+1,707,799
| +20% | +$89.2M |
|
218
DTE Energy
DTE
$29B
| $533M | 0.11% |
6,353,207
+3,189,632
| +101% | +$256M |
|
219
Verisk Analytics
VRSK
$24.2B
| $529M | 0.11% |
6,518,058
-424,592
| -6% | -$34.8M |
|
|
WP
220
DELISTED
Worldpay, Inc.
WP
| $528M | 0.1% |
8,854,031
-309,125
| -3% | -$17.9M |
|
221
Keurig Dr Pepper
KDP
$42.3B
| $528M | 0.1% |
5,819,695
+5,308,311
| +1,038% | +$465M |
|
|
SRCL
222
DELISTED
Stericycle Inc
SRCL
| $525M | 0.1% |
6,811,305
+516,772
| +8% | +$39M |
|
223
Idexx Laboratories
IDXX
$44.7B
| $519M | 0.1% |
4,428,320
-117,871
| -3% | -$13.5M |
|
224
MSCI
MSCI
$41.8B
| $518M | 0.1% |
6,571,001
-1,403,064
| -18% | -$113M |
|
|
CSRA
225
DELISTED
CSRA Inc.
CSRA
| $517M | 0.1% |
16,241,513
+11,327,832
| +231% | +$331M |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.